{"id":4637,"date":"2015-01-06T17:29:44","date_gmt":"2015-01-06T17:29:44","guid":{"rendered":"http:\/\/www.scienceofdme.org\/?p=4637"},"modified":"2015-01-06T17:29:44","modified_gmt":"2015-01-06T17:29:44","slug":"anti-vegf-agent-ranibizumab-gets-fda-breakthrough-therapy-designation-for-diabetic-retinopathy","status":"publish","type":"post","link":"https:\/\/www.scienceofdme.org\/fr\/anti-vegf-agent-ranibizumab-gets-fda-breakthrough-therapy-designation-for-diabetic-retinopathy\/","title":{"rendered":"(English) Anti-VEGF Agent Ranibizumab Gets FDA Breakthrough Therapy Designation for Diabetic Retinopathy"},"content":{"rendered":"<p><\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.scienceofdme.org\/fr\/wp-json\/wp\/v2\/posts\/4637"}],"collection":[{"href":"https:\/\/www.scienceofdme.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scienceofdme.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scienceofdme.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scienceofdme.org\/fr\/wp-json\/wp\/v2\/comments?post=4637"}],"version-history":[{"count":1,"href":"https:\/\/www.scienceofdme.org\/fr\/wp-json\/wp\/v2\/posts\/4637\/revisions"}],"predecessor-version":[{"id":4638,"href":"https:\/\/www.scienceofdme.org\/fr\/wp-json\/wp\/v2\/posts\/4637\/revisions\/4638"}],"wp:attachment":[{"href":"https:\/\/www.scienceofdme.org\/fr\/wp-json\/wp\/v2\/media?parent=4637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scienceofdme.org\/fr\/wp-json\/wp\/v2\/categories?post=4637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scienceofdme.org\/fr\/wp-json\/wp\/v2\/tags?post=4637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}